Transcat, Inc. logo TRNS - Transcat, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 8
HOLD 2
SELL 0
STRONG
SELL
0
| PRICE TARGET: $123.60 DETAILS
HIGH: $160.00
LOW: $94.00
MEDIAN: $113.00
CONSENSUS: $123.60
UPSIDE: 43.97%
AlphaVal

AlphaVal

Deterministic, archetype-aware fair value

Platform & Compounding FCF 50% confidence

Primary model: Two-stage FCF DCF

Valuation Signal Overvalued Strong
Trading 229.6% above fair value
Current Price $85.85
Bear Case $16.23 81.1% downside ($16.23 - $85.85) / $85.85 = -81.1% 6% stage 1 growth, 11% discount
Fair Value $26.05 69.7% downside ($26.05 - $85.85) / $85.85 = -69.7% 10% stage 1 growth, 11% discount
Bull Case $35.61 58.5% downside ($35.61 - $85.85) / $85.85 = -58.5% 13% stage 1 growth, 11% discount

Adjust Assumptions

9.7%
11.0%
3.0%

Key Value Driver

FCF growth rate (10% base case)

Terminal Value % of EV 39%
Implied Market Multiple 53.2x
Market is pricing in (growth) 22.0% vs our 9.7% base

Plain-Language Summary

Using a two-stage FCF DCF with 10% growth decelerating over 15 years, discounted at 11%, the base-case intrinsic value is $26.05 per share.

Analyst Consensus (External Reference)

Never blended into the bear/base/bull estimates above -- shown only as an outside comparison.

Average Target (10 analysts) $123.60
Analyst Range $94.00 – $160.00
Divergence from AlphaVal 79%

Warnings

Stock-based employee pay equals 140% of profits. This dilutes existing shareholders, so cash flow alone overstates what owners really earn.
Wall Street's average price target is $123.60 (from 10 analysts). Our estimate is 79% below the consensus -- consider that gap carefully.

Key Risks

  • P/E alone misleads — earnings depressed by growth investment
  • Cyclical or commodity businesses may be misclassified as platforms
  • Terminal value dominance suggests sensitivity to long-run assumptions